Morphine Reward in Dopaminedeficient Mice - PowerPoint PPT Presentation

1 / 26
About This Presentation
Title:

Morphine Reward in Dopaminedeficient Mice

Description:

... viral gene transfer to restore DA in the striatum (because DA deficient mice are ... 1. Locomotor tests were done using photo-beam activity cages. ... – PowerPoint PPT presentation

Number of Views:47
Avg rating:3.0/5.0
Slides: 27
Provided by: mattiam
Category:

less

Transcript and Presenter's Notes

Title: Morphine Reward in Dopaminedeficient Mice


1
Morphine Reward in Dopamine-deficient Mice
  • Hnasko TS, Sotak BN, Palmiter RD (2005). Nature
    438854-857.
  • Presented by Mattia M. Migliore
  • March 30, 2006

2
Introduction
  • First recorded reference to opium use occurred
    around 300 B.C.
  • Morphine is an analgesic first isolated from
    opium in 1806.
  • Morphines name came from Morpheus, the Greek god
    of dreams.
  • Opioids exert their effects by binding to opioid
    receptors (µ, d, and ?) which then couple to
    G-proteins, inhibit adenylate cyclase, activate
    K currents, and decrease Ca2 currents.
  • Much like other opioid analgesics, morphine has
    the potential to cause addiction.

http//www.heroin.org/papaver.jpg
http//www.sciencebase.com/images/ structure_of_mo
rphine.jpg
3
Introduction (cont)
  • Addiction can be defined as uncontrolled,
    compulsive use of a substance despite adverse
    consequences resulting from its use.
  • Addiction can result from repeated exposure to a
    substance, which then results in neurochemical
    adaptations in the reward system of the brain.
  • People can become addicted to drugs, alcohol,
    tobacco, gambling, sex, and even food.
  • Addiction is extremely difficult to study because
    no animal model of addiction even comes close to
    the complexity of the human condition.

www.hrmvideo.com/ resources/docs/2662.gif
4
Introduction (cont)
  • Drug addiction (also termed substance dependence)
    affects millions of people world wide.
  • The degree of drug abuse ranges from just
    occasional use to compulsive use ultimately
    resulting in fatal consequences.

www.WHO.org
5
Figure 1                                        
                                                  
                                                  
                                                  
                                                  
                                                  
  
(Nestler and Aghjanian, 1997)
6
(Goldstein and Volkow et., 2002).
7
Neurobiology of Addiction
  • Drugs of abuse illicit a feeling of euphoria or a
    high by activating the brains reward
    circuitry.
  • Dopamine has been believed to be responsible for
    feelings of reward for the last 30 yrs, and has
    been called the feel good neurotransmitter.
  • DA has long been implicated in the development of
    addiction.
  • Most drugs of abuse have been shown (via
    microdialysis studies) to increase extracellular
    DA levels and/or DA cell firing in the nucleus
    accumbens.

Goodman and Gilmans 11th edition.
8
Synthesis of Dopamine
http//web.indstate.edu/thcme/mwking/catecholamine
synthesis.jpg
9
Evidence supporting DAs role in reward
  • In 1954, Olds and Milner showed that direct
    electrical stimulation of the brain had powerful
    rewarding effects. Later, Olds et al. used
    intracranial self-administration of various
    substances to try to identify the
    neurotransmitters involved in reward.
  • Studies showed that DA receptor antagonists can
    inhibit the rewarding effects of food, and of
    intracranial self-stimulation (Zhou and Palmiter,
    1995).
  • Dopamine agonists and drugs that inhibit the DAT
    have been shown to cause animals to self
    administer these agents, and to develop a
    conditioned place preference (CPP) for these
    drugs.

10
Evidence supporting DAs role in reward (cont.)
  • Bilateral 6-OHDA lesions result in a severe
    decrease of activity, and the animals will refuse
    to eat or drink (an obliteration of the natural
    reward cues).
  • Schultz et al. showed that the anticipation of a
    reward (juice) in monkeys caused an increase in
    firing, and a change in the pattern of DA neuron
    firing.
  • Maldonado et al. showed that D2 receptor knock
    out mice do not show a CPP in response to
    morphine.
  • Volkow et al. used neuroimaging studies in humans
    to show that cocaine and methylphenidate increase
    brain dopamine levels, and this increase was
    associated with the feeling of a high.

11
Molecular Mechanism of Drug Addiction
12
(Nestler and Aghajanian, 1997)
13
Brain regions involved in drug addiction
(Golstein and Volkow, 2002).
14
(Volkow et al, 2003)
15
(Golstein and Volkow, 2002).
16
What makes some people become substance dependent?
17
Hypothesis
  • Dopamine is not an essential component of opiate
    responses, and that dopamine is not required for
    opioid mediated reward.

18
Methods
  • Dopamine deficient mice a complete deletion of
    the tyrosine hydroxylase (TH) encoding gene
    results in a deficiency in both DA and NE. In
    order to create only DA deficient mice, Hnasko
    et. Al used the TH encoding sequence to target
    the dopamine ß-hydroxylase (DBH) promoter in
    embryonic stem cells. Then DBH-TH /- mice were
    crossed with TH /- mice to yield TH /- DBH-TH
    /- which were then crossed with TH /- mice to
    yield dopamine deficient mice capable to still
    producing NE.

Zhou Q-YP, Richard D. (1995) Dopamine-deficient
mice are severely hypoactive, adipsic, and
aphagic. Cell 831197-1209.
19
Synthesis of Dopamine
http//web.indstate.edu/thcme/mwking/catecholamine
synthesis.jpg
20
Methods (cont.)
  • Mice required daily L-Dopa administration to
    induce them to eat. Morphine was administered
    18-24 hrs after L-Dopa .
  • Virally Rescued Dopamine Deficient Mice (vrDD)
    In order to perform the behavioral tests, they
    used a viral gene transfer to restore DA in the
    striatum (because DA deficient mice are slow and
    hypoactive).
  • Behavioural tests
  • 1. Locomotor tests were done using photo-beam
    activity cages. Morphine was administered IP at
    0,0.25,2.5,12.5, and 25 mg/kg.
  • 2. Tail flick tests were perfomed by
    using warm water baths. Briefly, the animals
    tail was submerged 0.5-1 cm in the water bath,
    and the latency to withdraw the tail was recorded
    (with a cut off time of 15s). The animals were
    tested three times/treatment and average used.
    Morphine was administered 30 min. Prior to test
    IP at 0,3,6,12, and 24 mg/kg.

21
Methods (cont.)
  • 3. Conditioned Place Preference (CPP) was
    performed using clear plastic boxes with 3
    chambers (1 neutral grey compartment in the
    middle, and 2 compartment with different colored
    walls, different textured flooring, and different
    scents). First, the mice were administered
    caffeine (18-24 hrs after L-Dopa treatment) and
    placed in the center and allowed to explore for
    25 min. On days 3-5 (conditioning phase), the
    animals received saline SQ in the morning and
    restricted to one compartment for 25 min, and
    then received morphine SQ and restricted to the
    opposite compartment for 25 min in the
    afternoons. Preference was tested on the sixth
    day. In the L-Dopa rescue, L-Dopa was
    administered similarly to the caffeine.

(Cami and Farre, 2003).
22
Results
23
(No Transcript)
24
(No Transcript)
25
(No Transcript)
26
(No Transcript)
27
www.unifr.ch/.../ Neurotransmitters/peptides.htm
28
(No Transcript)
29
(No Transcript)
30
Conclusions
  • Dopamine appears to be essential in the
    development of locomotor response to morphine.
  • Dopamine appears to play an important role in the
    level of analgesia experienced after morphine
    administration.
  • Dopamine may be required for reward seeking, but
    does not appear to be indispensable for
    morphines rewarding effects.
Write a Comment
User Comments (0)
About PowerShow.com